HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC Raises ‘Grave Concerns’ About China’s Cosmetic Regs, Possible WHO Treaty Noncompliance

Executive Summary

Foreign cosmetic product manufacturers may avoid the Chinese market if burdensome registration requirements aren’t modified and fairness issues addressed, the trade association says in comments to the Office of the US Trade Representative.

You may also be interested in...



Canada’s Cosmetic Animal-Testing Ban: What It Means For China Testing, New Ingredients, USA

Canada’s prohibitions on cosmetic animal testing enter into force in December, largely in line with EU, California and other bans around the globe, but with some notable distinctions. “Now it's really time to increase the pressure in the US – action can't be far behind,” says Brandi Halls, chief ethics officer at Lush Cosmetics, North America.

MoCRA Confidentiality For AE Reports? And Other Questions Raised At IBA Regulatory Forum

Independent Beauty Association president and CEO Don Frey, Kerry Tassopoulos of Platt Cheema Richmond PLLC, and IBA board member and Co-CEO and president Craig Weiss of the Consumer Product Testing Company fielded questions on MoCRA implementation at IBA’s 2023 Technical/Regulatory Forum.

PCPC’s International Efforts Focused On EU Microplastics Reg, China's CSAR Rollout

Francine Lamoriello, executive vice president of global strategies at the Personal Care Products Council, provided an overview of the group’s international activities at its 2022 Leadership Summit in Washington.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel